Invention Grant
- Patent Title: RET inhibitor
-
Application No.: US14429834Application Date: 2013-09-24
-
Publication No.: US10668075B2Publication Date: 2020-06-02
- Inventor: Tatsushi Kodama , Hiroshi Sakamoto , Toshiyuki Tsukaguchi
- Applicant: CHUGAI SEIYAKU KABUSHIKI KAISHA
- Applicant Address: JP Tokyo
- Assignee: Chugai Seiyaku Kabushiki Kaisha
- Current Assignee: Chugai Seiyaku Kabushiki Kaisha
- Current Assignee Address: JP Tokyo
- Agency: Foley & Lardner LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@1e117a9f
- International Application: PCT/JP2013/075621 WO 20130924
- International Announcement: WO2014/050781 WO 20140403
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; C07D401/04 ; C12Q1/6886 ; G01N33/574 ; C12Q1/6883 ; G01N33/573
Abstract:
A compound represented by the following general formula (I) [the symbol in the formula are as defined in the description], a salt thereof, or the like is a RET inhibitor or RET tyrosine kinase inhibitor that can be used as an agent for the prevention or treatment of disorders including cancers and cancer metastasis having mutations in RET.
Public/Granted literature
- US20150272958A1 RET INHIBITOR Public/Granted day:2015-10-01
Information query
IPC分类:
